Clinical Discussion: Emerging Front-Line Treatments in Metastatic Bladder Cancer: IO + Chemotherapy, IO + ADC Therapy, and the Role of Biomarkers
Medscape
America/New York GMT -4 summer
Description
Emerging Front-Line Treatments in Metastatic Bladder Cancer: IO + Chemotherapy, IO + ADC Therapy, and the Role of Biomarkers will feature a discussion by Memorial Sloan Kettering-based genitourinary oncology expert Dr Jonathan Rosenberg. He will cover emerging strategies and the use of biomarkers in this setting. There will be time allotted for questions at the end of the broadcast.
Clinical Discussion: Emerging Front-Line Treatments in Metastatic Bladder Cancer: IO + Chemotherapy, IO + ADC Therapy, and the Role of Biomarkers
Inglês
Previous registration necessary?
NO
YES
Simultaneous translation ?
NO
YES
Will it be recorded?
NO
YES
Speakers
Jonathan Rosenberg
Link to the Event
Banner to the Event
<< Previous event
Next event >>
Register your event here
Already have an account? LOGIN HERE. If You don't have an account you need to create a free account.